4.8 Article

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

期刊

NATURE COMMUNICATIONS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms11017

关键词

-

资金

  1. Swedish Cancer Society
  2. Swedish Science Council
  3. Knut and Alice Wallenberg Foundation
  4. Association for International Cancer Research/Worldwide Cancer Research [13-1295]
  5. Swiss National Science Foundation [31003A-130463]
  6. Oncosuisse grant [OC201200-08 -2007]
  7. European Research Council [294556 BBBARRIER]
  8. Leducq Foundation (Sphingonet)
  9. National Institute of Health [CA172983, CA175592]
  10. Wenner-Gren Foundation
  11. Swiss National Science Foundation (SNF) [31003A_130463] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

The specific role of VEGFA-induced permeability and vascular leakage in physiology and pathology has remained unclear. Here we show that VEGFA-induced vascular leakage depends on signalling initiated via the VEGFR2 phosphosite Y949, regulating dynamic c-Src and VE-cadherin phosphorylation. Abolished Y949 signalling in the mouse mutant Vegfr2(Y949F/Y949F) leads to VEGFA-resistant endothelial adherens junctions and a block in molecular extravasation. Vessels in Vegfr2(Y949F/Y949F) mice remain sensitive to inflammatory cytokines, and vascular morphology, blood pressure and flow parameters are normal. Tumour-bearing Vegfr2(Y949F/Y949F) mice display reduced vascular leakage and oedema, improved response to chemotherapy and, importantly, reduced metastatic spread. The inflammatory infiltration in the tumour micro-environment is unaffected. Blocking VEGFA-induced disassembly of endothelial junctions, thereby suppressing tumour oedema and metastatic spread, may be preferable to full vascular suppression in the treatment of certain cancer forms.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据